These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3732599)

  • 21. Structural basis for the variation in triclosan affinity to enoyl reductases.
    Pidugu LS; Kapoor M; Surolia N; Surolia A; Suguna K
    J Mol Biol; 2004 Oct; 343(1):147-55. PubMed ID: 15381426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
    Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
    Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a novel enoyl-acyl carrier protein reductase of diazaborine-resistant Rhodobacter sphaeroides mutant.
    Lee IH; Kim EJ; Cho YH; Lee JK
    Biochem Biophys Res Commun; 2002 Dec; 299(4):621-7. PubMed ID: 12459184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insight into the mechanism of action of and resistance to isoniazid: interaction of Mycobacterium tuberculosis enoyl-ACP reductase with INH-NADP.
    Argyrou A; Vetting MW; Blanchard JS
    J Am Chem Soc; 2007 Aug; 129(31):9582-3. PubMed ID: 17636923
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinetic and structural analysis of the increased affinity of enoyl-ACP (acyl-carrier protein) reductase for triclosan in the presence of NAD+.
    Kapoor M; Mukhi PL; Surolia N; Suguna K; Surolia A
    Biochem J; 2004 Aug; 381(Pt 3):725-33. PubMed ID: 15125687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A triclosan-resistant bacterial enzyme.
    Heath RJ; Rock CO
    Nature; 2000 Jul; 406(6792):145-6. PubMed ID: 10910344
    [No Abstract]   [Full Text] [Related]  

  • 27. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene.
    Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA
    Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the beta-carbon processing reactions of the mammalian cytosolic fatty acid synthase: role of the central core.
    Witkowski A; Joshi AK; Smith S
    Biochemistry; 2004 Aug; 43(32):10458-66. PubMed ID: 15301544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.
    Holas O; Ondrejcek P; Dolezal M
    J Enzyme Inhib Med Chem; 2015; 30(4):629-48. PubMed ID: 25383419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An inorganic iron complex that inhibits wild-type and an isoniazid-resistant mutant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
    Oliveira JS; Sousa EH; Basso LA; Palaci M; Dietze R; Santos DS; Moreira IS
    Chem Commun (Camb); 2004 Feb; (3):312-3. PubMed ID: 14740053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.
    Kapoor M; Gopalakrishnapai J; Surolia N; Surolia A
    Biochem J; 2004 Aug; 381(Pt 3):735-41. PubMed ID: 15139852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan.
    Ward WH; Holdgate GA; Rowsell S; McLean EG; Pauptit RA; Clayton E; Nichols WW; Colls JG; Minshull CA; Jude DA; Mistry A; Timms D; Camble R; Hales NJ; Britton CJ; Taylor IW
    Biochemistry; 1999 Sep; 38(38):12514-25. PubMed ID: 10493822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic and nuclear magnetic resonance study of the interaction of NADP+ and NADPH with chicken liver fatty acid synthase.
    Leanz GF; Hammes GG
    Biochemistry; 1986 Sep; 25(19):5617-24. PubMed ID: 3535882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallographic analysis of triclosan bound to enoyl reductase.
    Roujeinikova A; Levy CW; Rowsell S; Sedelnikova S; Baker PJ; Minshull CA; Mistry A; Colls JG; Camble R; Stuitje AR; Slabas AR; Rafferty JB; Pauptit RA; Viner R; Rice DW
    J Mol Biol; 1999 Nov; 294(2):527-35. PubMed ID: 10610777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase.
    Levy CW; Baldock C; Wallace AJ; Sedelnikova S; Viner RC; Clough JM; Stuitje AR; Slabas AR; Rice DW; Rafferty JB
    J Mol Biol; 2001 May; 309(1):171-80. PubMed ID: 11491286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triclosan targets lipid synthesis.
    McMurry LM; Oethinger M; Levy SB
    Nature; 1998 Aug; 394(6693):531-2. PubMed ID: 9707111
    [No Abstract]   [Full Text] [Related]  

  • 38. Enoyl-Acyl Carrier Protein Reductase I (FabI) Is Essential for the Intracellular Growth of Listeria monocytogenes.
    Yao J; Ericson ME; Frank MW; Rock CO
    Infect Immun; 2016 Dec; 84(12):3597-3607. PubMed ID: 27736774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enoyl-acyl-carrier-protein reductase and Mycobacterium tuberculosis InhA do not conserve the Tyr-Xaa-Xaa-Xaa-Lys motif in mammalian 11 beta- and 17 beta-hydroxysteroid dehydrogenases and Drosophila alcohol dehydrogenase.
    Baker ME
    Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):1029-30. PubMed ID: 7639680
    [No Abstract]   [Full Text] [Related]  

  • 40. Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs.
    Sivaraman S; Zwahlen J; Bell AF; Hedstrom L; Tonge PJ
    Biochemistry; 2003 Apr; 42(15):4406-13. PubMed ID: 12693936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.